This in turn meant that co-treatment with Ad-ΔB/TRAIL and Ad-ΔB/IL-12 exhibited simultaneous and efficient expression of both TRAIL and IL-12, and also didn’t interfere with viral replication, in human HCC cells. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.